UK

UK financial markets
#Association of the British Pharmaceutical Industry #Investment #Pharmaceutical industry #Research and development #UK #UK government

UK to lose £11bn in pharma R&D investment

The UK could lose out on £11 ($14.8) billion in pharmaceuticals research and development (R&D) investment by 2033, according to WPI Economics.  In the UK, the Voluntary Scheme or VPAG requires companies to pay the Department of Health and Social Care (DHSC) up to a quarter to a third of… Read More

#Business & Investment #News #Trending News

Great British Pounds, Investment
#BioNTech #Investment #Oncology #UK

BioNTech commits to up to £1 billion investment in the UK

Biopharmaceutical company BioNTech has announced a major investment of up to £1 ($1.3) billion over 10 years in the UK, potentially creating more than 400 new jobs in London and Cambridge.  The latest expansion of BioNTech’s presence in the UK builds on the company’s longstanding, positive strategic relationship and experience… Read More

#Business & Investment #News

London cancer hub
#Golden Triangle #London Cancer Hub #New facility #Research and development #UK

£1 billion for UK cancer research centre

Aviva Capital Partners (ACP) and developer Socius have unveiled plans for a new £1 ($1.3) billion development to create a leading centre for cancer research in Sutton, London, UK.  The development will be delivered on a 12-acre site at the London Cancer Hub, adjacent to The Institute… Read More

#News

Russell Abberley
#Appointment #Association of the British Pharmaceutical Industry #Biopharmaceuticals #UK

ABPI announces new president-elect

The Association of the British Pharmaceutical Industry (ABPI) has announced that Russel Abberley, the Vice President and General Manager of Amgen UK and Ireland, will become the organisation’s new president, after having held the role on an interim basis.   Abberley will take up the role on 13… Read More

#News

Downing Street, London, UK
#Funding #Life sciences #Research and development #UK #UK government

UK government commits £13.9 billion for R&D funding

The UK Department for Science, Innovation and Technology (DSIT) has set out how it will allocate £13.9 ($17.9) billion in funding for transformational research and development in the next year in areas like life sciences, green energy, engineering and beyond.   UK Research and Innovation (UKRI) – the… Read More

#News #Trending News

UK on global map
#BioIndustry Association #Oligonucleotides #UK

The UK should lead on oligonucleotides, says BIA

A new report from the BioIndustry Association (BIA) explains the UK’s leadership potential in oligonucleotide therapies.  The report ‘Oligos explainer: A new frontier in precision medicine’ highlights the transformative potential of oligonucleotide therapies.  The precision medicines, which use short DNA… Read More

#News

Great British Pounds, Investment
#Association of the British Pharmaceutical Industry #Pharmaceutical industry #UK #UK government

ABPI criticises “excessive” payment rates on branded medicines

The Association of the British Pharmaceutical Industry (ABPI) has warned that “rocketing payment rates are undermining the UK government’s efforts to make life sciences a key pillar of its industrial strategy”.  The government is proposing to raise the Statutory Scheme payment rate for newer branded medicines from… Read More

#News

#Advanced Therapies #Cell and gene therapy #Cell and Gene Therapy Catapult #UK

UK network to support innovation within advanced therapies

A new network aspires to create a world-leading regulatory environment in the UK for advanced therapies that supports companies in the development, trial, and launch of these treatments.   Cell and Gene Therapy Catapult (CGT Catapult) and the Birmingham Health Partners Centre for Regulatory Science and Innovation (CRSI)… Read More

#News

Vaccine research
#Innovate UK #Medical Research Council #MHRA #Regulatory #UK

New UK centres of excellence to accelerate delivery of treatments

Seven new Centres of Excellence for Regulatory Science and Innovation (CERSIs) are to receive funding up to £1 ($1.2) million each, to lead the way in safer, faster pathways for innovative medicines and devices.  The centres will be funded by Innovate UK in partnership with the Medicines… Read More

#News

UK on global map
#ABPI #Clinical trials #Life sciences #UK

UK starts to rebuild global position for industry clinical trials

A new report finds the UK’s global rankings for industry clinical trial delivery are improving.  However, further challenges must be overcome if the UK is to fight off fierce international competition to attract lucrative life science research.  In its annual report on the health of UK industry clinical trials, the… Read More

#Business & Investment #News #Trends & Analysis

Cannabis research
#Cannabinoid #Medicinal cannabis #Plant-based #UK

Cannabinoid pharmaceutical development: A golden opportunity

Professor Trevor Jones, Co-Chair of the Cannabinoid Research and Development Group (CRDG), discusses how the UK could become a leader in cannabinoid research. The UK is a global leader in biotechnology and one of the top countries for cannabinoid R&D - only Canada and the US publish more cannabinoid research. … Read More

#Exclusive Content #Opinion

CT scans of the brain
#Alzheimer's #Clinical trial #Dementia #UK

Accelerator to boost dementia clinical trial participation in UK 

A new initiative hopes to increase the number of people participating in dementia clinical trials in the UK, aiming to identify tens of thousands of potential trial participants.  The new ‘Dementia Trials Accelerator’ initiative hopes to address pharma-identified roadblocks to the delivery of commercial clinical trials in… Read More

#News

Cancer immunotherapy
#Immunotherapy #Oncology #The Francis Crick Institute #The Royal Marsden NHS Foundation Trust #UK

UK-wide programme to boost success of immunotherapy

A team of UK universities, hospitals and industry, led by the Francis Crick Institute and The Royal Marsden NHS Foundation Trust, have launched a new platform to understand immunotherapy response and side effects in cancer. The programme will be funded by £9 ($11.7) million from the… Read More

#Cancer Research #News

#Cystic fibrosis #Investment #LifeArc #UK

UK cystic fibrosis network to accelerate new therapeutics

LifeArc and Cystic Fibrosis Trust are jointly investing £15 million to establish a network of research hubs that will accelerate the discovery of novel diagnostics and therapeutics for lung infections. The Translational Innovation Hub Network for Lung Health and Infection will consist of four Innovation Hubs,… Read More

#News

Conference microphone
#Charles River #Events #UK

Charles River hosts drug discovery seminars

Charles River Laboratories is hosting two drug discovery seminars in the UK in September. The first will be in Cambridge on 25 September covering drug discovery capabilities, with the second at the company’s Portishead, UK site covering immuno-oncology, infectious disease capabilities on 26 September. Read More

#News

The Francis Crick Institute
#Drug discovery #Laboratory #Merck #MSD #The Francis Crick Institute #UK

Francis Crick and MSD boost UK drug research with new Skylab

The Francis Crick Institute and MSD have opened a new Skylab facility, extending the footprint of the Crick and expanding opportunities for collaboration between the two organisations. The new 11,800 square foot specialised life sciences laboratory is located on the roof space of the Crick and… Read More

#News